Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Fundamentals of CRISPR-Cas9: Gene-editing technology and basic

View through CrossRef
The CRISPR/Cas9 system provides a robust and multiplexable genome editing tool, enabling researchers to precisely manipulate specific genomic elements and facilitating the elucidation of target gene function in biology and diseases. CRISPR/Cas9 consists of a nonspecific Cas9 nuclease and a set of programmable sequence-specific CRISPR RNA (crRNA), which can guide Cas9 to cleave DNA and generate double-strand breaks at target sites. Subsequent cellular DNA repair processes lead to desired insertions, deletions, or substitutions at target sites. The particularity of CRISPR/Cas9-mediated DNA cleavage requires target sequences matching crRNA and a protospacer adjacent motif located downstream of target sequences. Here, we review the molecular mechanism, applications, and challenges of CRISPR/Cas9-mediated genome editing and the clinical therapeutic potential of CRISPR/Cas9 in the future.
Title: Fundamentals of CRISPR-Cas9: Gene-editing technology and basic
Description:
The CRISPR/Cas9 system provides a robust and multiplexable genome editing tool, enabling researchers to precisely manipulate specific genomic elements and facilitating the elucidation of target gene function in biology and diseases.
CRISPR/Cas9 consists of a nonspecific Cas9 nuclease and a set of programmable sequence-specific CRISPR RNA (crRNA), which can guide Cas9 to cleave DNA and generate double-strand breaks at target sites.
Subsequent cellular DNA repair processes lead to desired insertions, deletions, or substitutions at target sites.
The particularity of CRISPR/Cas9-mediated DNA cleavage requires target sequences matching crRNA and a protospacer adjacent motif located downstream of target sequences.
Here, we review the molecular mechanism, applications, and challenges of CRISPR/Cas9-mediated genome editing and the clinical therapeutic potential of CRISPR/Cas9 in the future.

Related Results

Application and Prospect of CRISPR-Cas9 Gene Editing Technology in Agricultural Breeding
Application and Prospect of CRISPR-Cas9 Gene Editing Technology in Agricultural Breeding
Since its inception in 2012, the gene editing technology CRISPR-Cas9 has rapidly become a revolutionary tool in the field of gene editing due to its high efficiency, specificity, a...
THE FUTURE OF MEDICINE: ADVANCING GENE THERAPY WITH CRISPR-CAS9’S EXACT PRECISION IN PEDIATRIC MALES
THE FUTURE OF MEDICINE: ADVANCING GENE THERAPY WITH CRISPR-CAS9’S EXACT PRECISION IN PEDIATRIC MALES
The revolutionary potential of CRISPR-Cas9 in medicine lies in its unparalleled precision in gene editing, heralding a new era for treating genetic disorders. This study focuses on...
CRISPR therapy: A revolutionary breakthrough in genetic medicine
CRISPR therapy: A revolutionary breakthrough in genetic medicine
Gene editing with CRISPR-Cas9 technology revolutionizes modern medicine by enabling precise DNA modifications. Initially discovered as a bacterial defense mechanism, the Cas9 enzym...
Alzheimer’s disease: A CRISPR/CAS9-mediated therapeutic approach
Alzheimer’s disease: A CRISPR/CAS9-mediated therapeutic approach
The degenerative nature of Alzheimer's disease (AD) and its severe effects on cognitive function present a major challenge to worldwide healthcare systems. CRISPR/Cas9, one of the ...
CRISPR Gene Editing on Human Embryos
CRISPR Gene Editing on Human Embryos
Background: With the recent development of CRISPR/Cas9 genome editing technology, the possibility to genetically influence the human germline (gametes and embryos) has become a sep...
CRISPR and gene editing for kidney diseases: where are we?
CRISPR and gene editing for kidney diseases: where are we?
ABSTRACT Genome editing technologies, particularly clustered regularly interspaced short palindromic repeats (CRISPR)-Cas9, have transformed biomedical research by e...
Co-delivery of Cas9 mRNA and guide RNAs for editing of LGMN gene represses breast cancer cell metastasis
Co-delivery of Cas9 mRNA and guide RNAs for editing of LGMN gene represses breast cancer cell metastasis
AbstractLegumain (or asparagine endopeptidase/AEP) is a lysosomal cysteine endopeptidase associated with increased invasive and migratory behavior in a variety of cancers. In this ...

Back to Top